154 related articles for article (PubMed ID: 37651277)
21. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis.
Martín J; Puig J; Darnell A; Donoso L
Semin Ultrasound CT MR; 2002 Feb; 23(1):62-78. PubMed ID: 11866223
[TBL] [Abstract][Full Text] [Related]
23. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
Terada T; Terasaki S; Nakanuma Y
Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
[TBL] [Abstract][Full Text] [Related]
24. Congestive Hepatopathy: Pathophysiology, Workup, and Imaging Findings with Pathologic Correlation.
Flory M; Elsayes KM; Kielar A; Harmath C; Dillman JR; Shehata M; Horvat N; Minervini M; Marks R; Kamaya A; Borhani AA
Radiographics; 2024 May; 44(5):e230121. PubMed ID: 38602867
[TBL] [Abstract][Full Text] [Related]
25. [Radiological diagnostic workup of liver tumors].
Raatschen HJ
Internist (Berl); 2020 Feb; 61(2):123-130. PubMed ID: 31919534
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.
Thompson SM; Garg I; Ehman EC; Sheedy SP; Bookwalter CA; Carter RE; Roberts LR; Venkatesh SK
Br J Radiol; 2018 Dec; 91(1092):20180345. PubMed ID: 30074820
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound.
Abd Alkhalik Basha M; Abd El Aziz El Sammak D; El Sammak AA
Clin Radiol; 2017 Oct; 72(10):901.e1-901.e11. PubMed ID: 28673446
[TBL] [Abstract][Full Text] [Related]
28. Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver Disease.
Cannella R; Cunha GM; Catania R; Chupetlovska K; Borhani AA; Fowler KJ; Furlan A
Magn Reson Imaging Clin N Am; 2021 Aug; 29(3):404-418. PubMed ID: 34243926
[TBL] [Abstract][Full Text] [Related]
29. Primary malignant tumours in the non-cirrhotic liver.
Lee DH; Lee JM
Eur J Radiol; 2017 Oct; 95():349-361. PubMed ID: 28987692
[TBL] [Abstract][Full Text] [Related]
30. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
31. Role of real-time shear-wave elastogarphy in differentiating hepatocellular carcinoma from other hepatic focal lesions.
Gad MAM; Eraky TE; Omar HM; Abosheaishaa HM
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):407-414. PubMed ID: 32345847
[TBL] [Abstract][Full Text] [Related]
32. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
Choi SH; Lee SS; Kim SY; Park SH; Park SH; Kim KM; Hong SM; Yu E; Lee MG
Radiology; 2017 Mar; 282(3):771-781. PubMed ID: 27797675
[TBL] [Abstract][Full Text] [Related]
33. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
34. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
Kim MJ; Lee S; An C
Eur Radiol; 2019 Sep; 29(9):5101-5110. PubMed ID: 30788586
[TBL] [Abstract][Full Text] [Related]
35. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
36. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
37. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
38. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
[TBL] [Abstract][Full Text] [Related]
39. Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY; Lee HC; Yim JH; Shim JH; Lim YS; Shin YM; Yu ES; Suh DJ
J Gastroenterol Hepatol; 2011 Jun; 26(6):1004-9. PubMed ID: 21251063
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings.
Di Martino M; Saba L; Bosco S; Rossi M; Miles KA; Di Miscio R; Lombardo CV; Tamponi E; Piga M; Catalano C
Eur Radiol; 2014 Jul; 24(7):1446-54. PubMed ID: 24770466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
